Retrospective analysis of management of inpatient adults with community-acquired pneumonia (findings of medical reports)
https://doi.org/10.18093/0869-0189-2009-0-1-44-50
Abstract
A retrospective comparative trial was performed to analyze management of adult patients with community-acquired pneumonia (CAP) hospitalized to a large clinical hospital of Moscow from January, 2006, to December, 2006. The study involved 42 in-patients with CAP (21 of them were discharged and 21 died). Time period from the onset of the disease to the hospital admission was 9.5 (95 % CI 6.4–12.6) days without a significant difference between the groups. Death occurred in 6.7 (95 % CI 2.7–10.7) days in average after presentation. Factors influencing the course of CAP in inpatient adults were inadequate and / or delayed antibacterial treatment before the admission, underestimation of severity of the disease in presentation to the hospital, uncommon use of computed tomography of the lungs to diagnose complications of CAP, poor adherence to current guidelines for management of patients with CAP
About the Authors
A. L. Chernyaev
ФГУ НИИ пульмонологии ФМБА России
Russian Federation
Russian Federation
E. P. Lukashenko
ФГУ НИИ пульмонологии ФМБА России
Russian Federation
Russian Federation
S. Yu. Chikina
ФГУ НИИ пульмонологии ФМБА России
Russian Federation
Russian Federation
References
1. Fine M.J., Smith M.A., Carson C.A. et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. J. A. M. A. 1996; 275: 134–141.
2. Baddour L.M., Yu V.L., Klugman K.P. et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteriemia. Am. J. Respir. Сrit. Care Med. 2004; 170: 440–444.
3. Yoshimoto A., Nakamura H., Fujimura M., Nakao S. Severe community-acquired pneumonia in intensive care unit: risk factors for mortality. Internal Med. 2005; 44: 710–716.
4. Синопальников А.И. Бактериальная пневмония. В кн.: Чучалин А.Г. (ред.) Респираторная медицина. М.: Гэотар-Медиа; 2007; т. 1: 474–510.
5. Черемисина И.А. Частота патологии легких и уровень клинической диагностики в Санкт-Петербурге по данным аутопсий: Автореф. дис. … канд. мед. наук. СПб.; 2000.
6. Lim W.S. et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377–382.
7. Баишева Г.М., Зулкарнеев Р.Х. Причины летальности от внебольничной пневмонии. В кн.: XV Национальный конгресс по болезням органов дыхания: Сборник тезисов. М.; 2005. 96.
8. Верткин А.Л., Зайратьянц О.В., Вовк Е.И., Дадыкина А.В. Рассуждения терапевта и морфолога о причинах ошибок диагностики и лечения внебольничной пневмонии. В кн.: XV Национальный конгресс по болезням органов дыхания: Сборник тезисов. М.; 2005. 89.
9. Коротич О.П., Круглякова Л.В., Сулима М.В. и др. Анализ причин смерти больных внебольничной пневмонией. В кн.: XV Национальный конгресс по болезням органов дыхания: Сборник тезисов. М.; 2005. 99.
10. Бурковская Е.Н., Боева И.А., Ситникова Е.А. Внебольничная пневмония тяжелого течения: причины и осложнения. В кн.: XV Национальный конгресс по болезням органов дыхания: Сборник тезисов. М.; 2005. 96.
11. Чучалин А.Г., Синопальников А.И. (ред.). Внебольничная пневмония у взрослых. Клинические рекомендации. М.: Атмосфера; 2005.
12. Malmon M., Nopmaneejumruslers C., Marras T.K. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur. Respir. J. 2008; 31: 1068–1076.
13. Marrie T.J., Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia. A prospective study of patients not initially admitted to the ICU. Chest 2005; 127: 1260–1270.
14. Garcia-Vidal C., Fernandez-Sabe N., Carratala J. et al. Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur. Respir. J. 2008; 32: 733–739.
15. Menéndez R., Ferrando D., Vallés J.M., Vallterra J. Influence of deviation from guidelines on outcome of communityacquired pneumonia. Chest 2002; 122: 612–617.
16. Антипин А.Н. Оптимизация антибактериальной терапии внебольничных пневмоний в стационаре. В кн.: XV Национальный конгресс по болезням органов дыхания: Сборник тезисов. М.; 2005. 89.
17. Dean N.C., Bateman K.A., Donnelly S.M. et al. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest 2006; 130: 794–799.
18. Menéndez R., Torres A., Zalacain R. et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax 2004; 59: 960–965.
19. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001; 56: 1–64.
20. Mandell L., Bartlett J.G., Dowell S.F. et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 2003; 37: 1405–1433.
21. Meehan T.P., Fine M.J., Krumholz H.M. et al. Quality of care, process, and outcome in elderly patients with pneumonia. J. A. M. A. 1997; 278 (23): 2080–2084.
22. Houck P.M., Bratzler D.W., Nsa W. et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 2004; 164 (6): 637–644.
23. Houck P.M. Antibiotics and pneumonia. Is timing everything or just a cause of more problems? Chest 2006; 130 (1): 1–3.
Review
For citations:
Chernyaev A.L., Lukashenko E.P., Chikina S.Yu. Retrospective analysis of management of inpatient adults with community-acquired pneumonia (findings of medical reports). PULMONOLOGIYA. 2009;(1):44-50. (In Russ.) https://doi.org/10.18093/0869-0189-2009-0-1-44-50
Views:
600
Email this article 